Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.68B |
| 2 |
Synchrony
SYF
|
+$441M |
| 3 |
Meta Platforms (Facebook)
META
|
+$370M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$349M |
| 5 |
Comcast
CMCSA
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$783M |
| 2 |
Morgan Stanley
MS
|
+$518M |
| 3 |
Lowe's Companies
LOW
|
+$474M |
| 4 |
Visa
V
|
+$425M |
| 5 |
Netflix
NFLX
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.01% |
| 2 | Technology | 4.76% |
| 3 | Consumer Discretionary | 3.82% |
| 4 | Industrials | 3.81% |
| 5 | Communication Services | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
3401
DELISTED
Array Biopharma Inc
ARRY
| $2.93M | ﹤0.01% |
205,578
-114,994
| -36% | -$1.74M |
|
|
CLVS
3402
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.93M | ﹤0.01% |
162,900
+49,600
| +44% | +$1.01M |
|
3403
PUT
Waters Corp
WAT
$40.5B
| $2.92M | ﹤0.01% |
15,500
-9,900
| -39% | -$1.88M |
|
3404
CALL
Tower Semiconductor
TSEM
$30B
| $2.92M | ﹤0.01% |
198,300
+51,300
| +35% | +$855K |
|
|
LSI
3405
DELISTED
Life Storage, Inc.
LSI
| $2.92M | ﹤0.01% |
47,112
-88,484
| -65% | -$5.61M |
|
|
MZTI
3406
The Marzetti Company
MZTI
$3.18B
| $2.92M | ﹤0.01% |
16,507
+288
| +2% | +$49K |
|
3407
PUT
Applied Optoelectronics
AAOI
$12.7B
| $2.92M | ﹤0.01% |
189,100
-63,300
| -25% | -$1.28M |
|
3408
Onto Innovation
ONTO
$20.3B
| $2.92M | ﹤0.01% |
106,754
+1,007
| +1% | +$31K |
|
3409
State Street SPDR Russell 1000 Yield Focus ETF
ONEY
$681M
| $2.91M | ﹤0.01% |
+47,082
| New | +$3.19M |
|
3410
PUT
uniQure
QURE
$3.37B
| $2.91M | ﹤0.01% |
101,000
+40,200
| +66% | +$1.12M |
|
3411
CALL
3D Systems Corp
DDD
$616M
| $2.91M | ﹤0.01% |
286,200
-16,500
| -5% | -$226K |
|
3412
Vanguard Morningstar Small-Cap ETF
VB
$83.6B
| $2.91M | ﹤0.01% |
22,046
+17,514
| +386% | +$2.55M |
|
3413
PUT
Tenet Healthcare
THC
$21.6B
| $2.91M | ﹤0.01% |
169,700
-53,900
| -24% | -$1.3M |
|
3414
CALL
Vanguard Dividend Appreciation ETF
VIG
$114B
| $2.91M | ﹤0.01% |
29,700
-37,300
| -56% | -$3.89M |
|
|
MANT
3415
DELISTED
Mantech International Corp
MANT
| $2.91M | ﹤0.01% |
55,619
-17,412
| -24% | -$977K |
|
3416
PUT
Brighthouse Financial
BHF
$3.37B
| $2.9M | ﹤0.01% |
95,300
+11,300
| +13% | +$441K |
|
|
SAGE
3417
DELISTED
Sage Therapeutics
SAGE
| $2.9M | ﹤0.01% |
30,317
-148,705
| -83% | -$17M |
|
3418
PUT
iShares TIPS Bond ETF
TIP
$14.7B
| $2.9M | ﹤0.01% |
26,500
-9,500
| -26% | -$1.04M |
|
3419
Nexa Resources
NEXA
$1.88B
| $2.9M | ﹤0.01% |
243,797
-100,830
| -29% | -$1.23M |
|
3420
Forward Air
FWRD
$640M
| $2.9M | ﹤0.01% |
52,889
-2,808
| -5% | -$173K |
|
3421
General Dynamics
GD
$107B
| $2.9M | ﹤0.01% |
18,444
-11,260
| -38% | -$2.02M |
|
|
LLL
3422
CALL
DELISTED
L3 Technologies, Inc.
LLL
| $2.9M | ﹤0.01% |
16,700
-12,800
| -43% | -$2.47M |
|
3423
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.43B
| $2.9M | ﹤0.01% |
94,936
+56,078
| +144% | +$1.83M |
|
3424
PUT
Tapestry
TPR
$25.7B
| $2.9M | ﹤0.01% |
85,800
-43,300
| -34% | -$1.74M |
|
|
ESPR
3425
DELISTED
Esperion Therapeutics
ESPR
| $2.9M | ﹤0.01% |
62,945
+1,515
| +2% | +$73K |
|
Similar funds
Ken Griffin's Q4 2018 Portfolio in Review
As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.
- Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
- Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
- Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
- Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
- Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
- Ken Griffin opened 1,236 new positions and closed 1,371 in Q4 2018.
- Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.